SEC Filing Summary for AMGEN INC

Robert Eckert, a director at AMGEN INC, acquired 665 shares of Common Stock on May 19, 2026, at a price of $0.0 per share. This transaction was made under the Amgen Inc. 2009 Director Incentive Program. Following this acquisition, Eckert now holds 26,251 shares of Common Stock. The shares acquired include 3,943 Dividend Equivalents (DEs) which are subject to a dividend reinvestment plan and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule.